UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2000, ISBN 1572305843, xii, 388
Book
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2014, Volume 121, Issue 11, pp. 2247 - 2254
Ophthalmology | Life Sciences & Biomedicine | Science & Technology | Diabetic Retinopathy - drug therapy | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Intravitreal Injections | Recombinant Fusion Proteins - adverse effects | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Male | Laser Coagulation | Diabetes Mellitus, Type 1 - complications | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Diabetic Retinopathy - physiopathology | Angiogenesis Inhibitors - therapeutic use | Female | Angiogenesis Inhibitors - adverse effects | Visual Acuity - physiology | Diabetes Mellitus, Type 2 - complications | Double-Blind Method | Tomography, Optical Coherence | Diabetic Retinopathy - surgery | Macular Edema - surgery | Macular Edema - physiopathology | Macular Edema - drug therapy | Aged | Receptors, Vascular Endothelial Growth Factor - adverse effects | Medical colleges | Dropsy | Edema | Endothelial growth factors | Analysis | Diabetes | Consulting services | Index Medicus
Journal Article
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2012, Volume 119, Issue 12, pp. 2537 - 2548
Ophthalmology | Life Sciences & Biomedicine | Science & Technology | Biological and medical sciences | Miscellaneous | Medical sciences | Retinopathies | Receptors, Vascular Endothelial Growth Factor | Antibodies, Monoclonal, Humanized - therapeutic use | Prospective Studies | Double-Blind Method | Intravitreal Injections | Sickness Impact Profile | Recombinant Fusion Proteins - adverse effects | Humans | Recombinant Fusion Proteins - therapeutic use | Male | Treatment Outcome | Wet Macular Degeneration - physiopathology | Wet Macular Degeneration - diagnosis | Retreatment | Wet Macular Degeneration - drug therapy | Ranibizumab | Angiogenesis Inhibitors - therapeutic use | Female | Aged | Visual Acuity - physiology | Fluorescein Angiography | Macular degeneration | Physiological aspects | Medical colleges | Vascular endothelial growth factor | Consulting services | Analysis | Index Medicus
Journal Article
Annals of internal medicine, ISSN 0003-4819, 03/2020, Volume 172, Issue 6, pp. 369 - 380
Journal Article
Review of scientific instruments, ISSN 0034-6748, 11/2016, Volume 87, Issue 11, pp. 114503 - 114503
Journal Article
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2009, Volume 116, Issue 11, pp. 2141 - 2148.e1
Ophthalmology | Life Sciences & Biomedicine | Science & Technology | Biological and medical sciences | Miscellaneous | Medical sciences | Retinopathies | Choroidal Neovascularization - diagnosis | Follow-Up Studies | Recombinant Fusion Proteins - adverse effects | Tomography, Optical Coherence | Humans | Male | Treatment Outcome | Macular Degeneration - diagnosis | Macular Degeneration - drug therapy | Receptors, Vascular Endothelial Growth Factor - administration & dosage | Injections | Maximum Tolerated Dose | Choroidal Neovascularization - drug therapy | Aged, 80 and over | Vitreous Body | Female | Aged | Visual Acuity - physiology | Recombinant Fusion Proteins - administration & dosage | Fluorescein Angiography | Macular degeneration | Medical research | Care and treatment | Physiological aspects | Medicine, Experimental | Vascular endothelial growth factor | Consulting services | Protein binding | Index Medicus
Journal Article
Arteriosclerosis, thrombosis, and vascular biology, ISSN 1079-5642, 07/1996, Volume 16, Issue 7, pp. 831 - 842
lipid oxide | inflammatory reaction | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Medical sciences | Atherosclerosis (general aspects, experimental research) | Blood and lymphatic vessels | Arteriosclerosis - etiology | Animals | Humans | Lipoproteins, HDL - metabolism | Lipoproteins, LDL - metabolism | Phospholipids - metabolism | Arteriosclerosis - genetics | Lipid Peroxidation | Arteries - metabolism | Index Medicus
Journal Article
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2012, Volume 119, Issue 8, pp. 1658 - 1665
Ophthalmology | Life Sciences & Biomedicine | Science & Technology | Miscellaneous | Diabetes. Impaired glucose tolerance | Retinopathies | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Diabetic Retinopathy - drug therapy | Receptors, Vascular Endothelial Growth Factor | Double-Blind Method | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Male | Treatment Outcome | Laser Coagulation | Diabetes Mellitus, Type 1 - complications | Diabetic Retinopathy - surgery | Diabetic Retinopathy - therapy | Macular Edema - therapy | Diabetic Retinopathy - physiopathology | Retreatment | Macular Edema - surgery | Macular Edema - physiopathology | Macular Edema - drug therapy | Female | Visual Acuity - physiology | Diabetes Mellitus, Type 2 - complications | Recombinant Fusion Proteins - administration & dosage | Diabetic retinopathy | Dropsy | Edema | Medical colleges | Consulting services | Vascular endothelial growth factor | Endothelium | Index Medicus
Journal Article
9.
Full Text
Intravitreal Aflibercept Injection for Macular Edema Due to Central Retinal Vein Occlusion
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2014, Volume 121, Issue 7, pp. 1414 - 1420.e1
Journal Article
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2016, Volume 123, Issue 11, pp. 2376 - 2385
Journal Article
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2015, Volume 122, Issue 10, pp. 2044 - 2052
Journal Article
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2011, Volume 118, Issue 9, pp. 1819 - 1826
Ophthalmology | Life Sciences & Biomedicine | Science & Technology | Miscellaneous | Diabetes. Impaired glucose tolerance | Retinopathies | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Diabetic Retinopathy - drug therapy | Receptors, Vascular Endothelial Growth Factor | Intravitreal Injections | Recombinant Fusion Proteins - adverse effects | Humans | Middle Aged | Male | Laser Coagulation | Diabetes Mellitus, Type 1 - complications | Diabetic Retinopathy - physiopathology | Female | Visual Acuity - physiology | Diabetes Mellitus, Type 2 - complications | Recombinant Fusion Proteins - administration & dosage | Double-Blind Method | Tomography, Optical Coherence | Treatment Outcome | Diabetic Retinopathy - surgery | Diabetic Retinopathy - therapy | Macular Edema - therapy | Retreatment | Macular Edema - surgery | Macular Edema - physiopathology | Macular Edema - drug therapy | Retina - pathology | Dropsy | Edema | Diabetic retinopathy | Care and treatment | Product development | Consulting services | Vascular endothelial growth factor | Endothelium | Index Medicus
Journal Article